HUM vs IDYA · P/E 39, rev $117.76B vs rev $7.0M
Humana Inc (HUM) versus Ideaya Biosciences Inc (IDYA) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Ideaya Biosciences Inc (IDYA) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported IDYA revenue for 2024-12-31 was $7.0M. Net income was -$274.5M. Revenue was down 70.1% from 2023-12-31 to 2024-12-31. IDYA currently screens at market cap $2.96B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. IDYA currently screens at market cap $2.96B.
Not investment advice. Open the HUM and IDYA stock pages for the full models.
Not investment advice.